A Study Of Indian Patients Receiving Therapy For Systemic Fungal Infections

CompletedOBSERVATIONAL
Enrollment

23

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Systemic Fungal Infections
Interventions
DRUG

voriconazole

Patients must have received (in the Intensive Care Unit \[ICU\] at study entry) at least 1 day therapy with systemic antifungal agent for treatment of a proven or suspected fungal infection. The decision regarding choice of antifungal agent would lie with the treating physician and will necessarily precede and be independent of the decision to enroll a patient into the study.

Trial Locations (3)

411004

Pfizer Investigational Site, Pune

411 001

Pfizer Investigational Site, Pune

110 076

Pfizer Investigational Site, New Delhi

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00721578 - A Study Of Indian Patients Receiving Therapy For Systemic Fungal Infections | Biotech Hunter | Biotech Hunter